SK bioscience Co.,Ltd. (302440.KS)
KRW 54700.0
(-5.36%)
KRW 54700.0
(-5.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 29.34 Billion | -124.95 Billion | 536.59 Billion | 120.22 Billion | 35.97 Billion | 14.9 Billion |
| Net Income | 22.31 Billion | 122.45 Billion | 355.13 Billion | 32.88 Billion | 14.67 Billion | 420.84 Million |
| Depreciation & Amortization | 34.76 Billion | 27.23 Billion | 18.77 Billion | 16.52 Billion | 14.54 Billion | 6.59 Billion |
| Deferred income taxes | - | - | - | -719.86 Million | -5.58 Billion | 4.32 Billion |
| Stock-based compensation | - | - | - | 575.45 Million | 300.23 Million | 25.02 Million |
| Change in working capital | -18.39 Billion | -208.37 Billion | 44 Billion | 66.4 Billion | 8.06 Billion | 1.11 Billion |
| Other non-cash items | -9.34 Billion | -66.26 Billion | 118.67 Billion | 4.54 Billion | 3.97 Billion | 2.41 Billion |
| Investing Cash Flow | -45.27 Billion | 272.64 Billion | -1421.94 Billion | -108.09 Billion | -2.64 Billion | -17.64 Billion |
| Investments in PPE | -50.29 Billion | -76.48 Billion | -44.46 Billion | -10.19 Billion | -23.96 Billion | -6.3 Billion |
| Acquisitions | 535 Thousand | 34.56 Million | 5.81 Billion | 197.83 Million | 99.92 Million | - |
| Investment purchases | -111.39 Billion | -1 Billion | -1385.6 Billion | -102.39 Billion | -99.92 Million | -11.32 Billion |
| Sales/Maturities of investments | 118.77 Billion | 353.05 Billion | 990 Million | 3.26 Billion | 21.01 Billion | - |
| Other Investing Activities | -2.36 Billion | -2.95 Billion | 1.32 Billion | 1.04 Billion | 302.46 Million | -9.15 Million |
| Financing Cash Flow | -89.58 Billion | -19.86 Billion | 958.38 Billion | -1.53 Billion | -23.43 Billion | 837.86 Million |
| Debt repayment | -83.55 Billion | -64.19 Billion | -35.57 Billion | -1.23 Billion | -23.43 Billion | -10 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 397.59 Million | 2.61 Billion | 983.25 Billion | -301.45 Million | - | 10.98 Billion |
| Other Financing Activities | -6.42 Billion | 41.71 Billion | 10.69 Billion | -301.45 Million | - | -144 Million |
| Accounts receivables | 71.16 Billion | -44.64 Billion | -398.64 Million | -14.6 Billion | 12.25 Billion | -12.66 Billion |
| Accounts payables | -7.68 Billion | -52.75 Billion | 46.53 Billion | -866.88 Million | 7.29 Billion | -7.02 Billion |
| Inventory | 52.88 Billion | -96.22 Billion | -70.33 Billion | -31.57 Billion | -6.88 Billion | 6.87 Billion |
| Other working capital | -134.76 Billion | -14.74 Billion | 68.2 Billion | 113.45 Billion | -4.6 Billion | -5.76 Billion |
| Cash at beginning of period | 225.28 Billion | 98.02 Billion | 24.97 Billion | 14.38 Billion | 4.48 Billion | 6.39 Billion |
| Cash at end of period | 127.02 Billion | 225.28 Billion | 98.02 Billion | 24.97 Billion | 14.38 Billion | 4.48 Billion |
| Capital Expenditure | -50.29 Billion | -76.48 Billion | -44.46 Billion | -10.19 Billion | -23.96 Billion | -6.3 Billion |
| Effect of forex changes on cash | 7.25 Billion | -561.87 Million | 22.25 Million | 10.00 | - | -10.00 |
| Net cash flow / Change in cash | -98.26 Billion | 127.25 Billion | 73.05 Billion | 10.59 Billion | 9.89 Billion | -1.9 Billion |
| Free Cash Flow | -20.94 Billion | -201.44 Billion | 492.12 Billion | 110.02 Billion | 12 Billion | 8.59 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.4 Billion | -13.71 Billion | 22.31 Billion | 4.16 Billion | 48.39 Billion | -15.97 Billion |
| Depreciation & Amortization | 9.07 Billion | 9.12 Billion | 34.76 Billion | 9.09 Billion | 8.87 Billion | 8.52 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -13.01 Billion | -4.59 Billion | -18.39 Billion | 62 Billion | 27.41 Billion | -62.8 Billion |
| Other non-cash items | 437.42 Million | 3.82 Billion | -9.34 Billion | -13.8 Billion | 60.6 Billion | -33.62 Billion |
| Investing Cash Flow | 98.43 Billion | 60.6 Billion | -45.27 Billion | -178.33 Billion | -139.42 Billion | 137.82 Billion |
| Investments in PPE | -10.26 Billion | -75.31 Billion | -50.29 Billion | -13.35 Billion | -18.52 Billion | -11.15 Billion |
| Acquisitions | 1 Million | 965.54 Thousand | 535 Thousand | - | 111.39 Billion | - |
| Investment purchases | -2.95 Billion | - | -111.39 Billion | - | -111.39 Billion | - |
| Sales/Maturities of investments | 111.71 Billion | 135.91 Billion | 118.77 Billion | -164.99 Billion | -9.52 Billion | 148.95 Billion |
| Other Investing Activities | -54.76 Million | 4 Million | -2.36 Billion | 4.05 Million | -111.36 Billion | 20.01 Million |
| Financing Cash Flow | -3.14 Billion | 77 Billion | -89.58 Billion | -2.61 Billion | -2.97 Billion | -35.58 Billion |
| Debt repayment | -3.14 Billion | -80 Billion | -83.55 Billion | - | - | -38 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 397.59 Million | 397.59 Million | - | - |
| Other Financing Activities | -3.14 Billion | - | -6.42 Billion | -3.01 Billion | - | 2.41 Billion |
| Accounts receivables | 3.96 Billion | -4.37 Billion | 71.16 Billion | 46.52 Billion | 34.29 Billion | -35.59 Billion |
| Accounts payables | 2.85 Billion | 5.15 Billion | -7.68 Billion | -6.94 Billion | 4.31 Billion | -1.08 Billion |
| Inventory | -13.77 Billion | -8.73 Billion | 52.88 Billion | 62.82 Billion | 49.43 Billion | -41.57 Billion |
| Other working capital | -6.07 Billion | 3.35 Billion | -134.76 Billion | -40.39 Billion | -60.63 Billion | 15.44 Billion |
| Cash at beginning of period | 234.89 Billion | 127.02 Billion | 225.28 Billion | 247.51 Billion | 243.75 Billion | 242.65 Billion |
| Cash at end of period | 291.57 Billion | 234.89 Billion | 127.02 Billion | 127.02 Billion | 247.51 Billion | 243.75 Billion |
| Capital Expenditure | -10.26 Billion | -75.31 Billion | -50.29 Billion | -13.35 Billion | -18.52 Billion | -11.15 Billion |
| Effect of forex changes on cash | 1.39 Billion | 1.82 Billion | 7.25 Billion | -1 Billion | 865.68 Million | 2.74 Billion |
| Net cash flow / Change in cash | 56.67 Billion | 107.87 Billion | -98.26 Billion | -120.48 Billion | 3.75 Billion | 1.09 Billion |
| Free Cash Flow | -50.27 Billion | -106.88 Billion | -20.94 Billion | 48.11 Billion | 126.76 Billion | -115.03 Billion |
VIT
WJRYF
NCTY
MCB
301018
ARC